Post Blogs, Photos, Youtube, Vimeo Videos, Topics, Events, Groups.
+ Larger Font | - Smaller Font

Welcome to Robins Social Network

Be part of the community and join us today!

Over 35 CMOs / CDMOs in China claim to offer a variety of services related to development and manufacturing of a wide range of biotherapeutic products, claims Roots Analysis


Owing to benefits, such as reduced manufacturing costs, availability of cheap and skilled labor, and a supportive regulatory landscape, biopharmaceutical developers from across the globe, are increasingly outsourcing their manufacturing operations to China based CMOs. Further, in order to meet the growing demand for their services, Chinese CMOs are actively consolidating / expanding their capabilities through partnerships and / or dedicated expansion initiatives.  


To order this 250+ page report, which features 100+ figures and 120+ tables, please visit this link


The USD 2.6 billion (by 2030) financial opportunity within the China biopharmaceutical contract manufacturing market has been analyzed across the following segments:

§  Type of Product 

  • API
  • FDF


§  Type of Expression System Used

  • Mammalian
  • Microbial
  • Others


§  Scale of Operation

  • Preclinical / Clinical
  • Commercial


§  Size of Manufacturer

  • Small
  • Mid-sized
  • Large / Very Large


§  Type of Biologic 

  • Antibody 
  • Vaccine
  • Others


The China Biopharmaceutical Contract Manufacturing Market, 2020-2030report features the following companies, which we identified to be key players in this domain:

§  ChemPartner Biologics

§  JHL Biotech

§  JOINN Biologics

§  MabPlex

§  Mycenax Biotech

§  WuXi AppTec


Table of Contents


1. Preface

2. Executive Summary

3. Introduction

4. Case Study: Comparison of Small Molecules and Large Molecules

5. Competitive Landscape

6. Company Profiles

7. Partnerships 

8. Recent Expansions

9. Clinical Trial Analysis

10. Regional Capability Analysis

11. Capacity Analysis

12. Big Pharma Biopharmaceutical Manufacturing Initiatives in China

13. Make Versus Buy Decision Making Framework

14. Market Sizing and Opportunity Analysis


15. COVID-19 Impact on China Biopharmaceutical CMO Market


16. SWOT Analysis


17. Future of the China Biopharmaceutical CMO Market


18. Interview Transcripts






To purchase a copy, please visit


Contact Details

Gaurav Chaudhary

+1 (415) 800 3415  


on January 27 at 6:37

Comments (0)

Become a member and experience a unique opportunity to post blogs, photos, Youtube Vimeo videos, topics, events, and create groups on Robin's Social Networking Site. Use Robin's Social to sell products, services and market your business when posting blogs.

By registering and posting content, you agree to the terms listed at... Posting Terms and Conditions. Enjoy!

© 2022 Content By Members. All Rights Reserved.